Concert Genetics Earns Patent for Innovative Methods of Automating Genetic Test Coverage and Payment Accuracy

Concert Genetics Earns Patent for Innovative Methods of Automating Genetic Test Coverage and Payment Accuracy
Concert links 160,000 genetic tests to coverage criteria, automates accurate payment, and supports high-value clinical test ordering
News provided by
Share this article
Share this article
NASHVILLE, Tenn., June 9, 2021 /PRNewswire/ -- The U.S. Patent and Trademark Office has issued Concert Genetics patent
US10,896,405B1 for innovative methods that enable real-time coverage determination and accurate reimbursement of genetic tests, the company announced today.
As the patent describes, Concert's system converts health plan medical policies, typically text documents, into machine-readable criteria, and then links the criteria to every genetic test on the market. This system leverages Concert's platform for collecting, standardizing and organizing genetic test information, represented in patent

Related Keywords

United States ,American ,Rob Metcalf ,Nick Tazik ,Gillian Hooker ,Trademark Office ,National Society Of Genetic Counselors ,Concert Genetics ,Chief Scientific Officer ,Past President ,National Society ,American Journal ,Medical Genetics ,ஒன்றுபட்டது மாநிலங்களில் ,அமெரிக்கன் ,கொள்ளை மெட்‌க்யாஃப் ,கில்லியன் ஹூக்கர் ,முத்திரை அலுவலகம் ,தேசிய சமூகம் ஆஃப் ஜெநெடிக் ஆலோசகர்கள் ,கச்சேரி ஜெநெடிக்ஸ் ,தலைமை அறிவியல் அதிகாரி ,கடந்த காலம் ப்ரெஸிடெஂட் ,தேசிய சமூகம் ,அமெரிக்கன் இதழ் ,மருத்துவ ஜெநெடிக்ஸ் ,